KOPS - Das Institutionelle Repositorium der Universität Konstanz

Generation of Genetically-Modified Human Differentiated Cells for Toxicological Tests and the Study of Neurodegenerative Diseases

Generation of Genetically-Modified Human Differentiated Cells for Toxicological Tests and the Study of Neurodegenerative Diseases

Zitieren

Dateien zu dieser Ressource

Prüfsumme: MD5:03a92e9ac25b676de9ed4834a6eb7bdf

SCHILDKNECHT, Stefan, Christiaan KARREMAN, Dominik PÖLTL, Liudmila EFREMOVA, Cornelius KULLMANN, Simon GUTBIER, Anne-Kathrin KRUG, Diana SCHOLZ, Hanne R. GERDING, Marcel LEIST, 2013. Generation of Genetically-Modified Human Differentiated Cells for Toxicological Tests and the Study of Neurodegenerative Diseases. In: Alternatives to animal experimentation : ALTEX. 30(4), pp. 427-444. ISSN 1868-596X

@article{Schildknecht2013Gener-25648, title={Generation of Genetically-Modified Human Differentiated Cells for Toxicological Tests and the Study of Neurodegenerative Diseases}, year={2013}, doi={10.14573/altex.2013.4.427}, number={4}, volume={30}, issn={1868-596X}, journal={Alternatives to animal experimentation : ALTEX}, pages={427--444}, author={Schildknecht, Stefan and Karreman, Christiaan and Pöltl, Dominik and Efremova, Liudmila and Kullmann, Cornelius and Gutbier, Simon and Krug, Anne-Kathrin and Scholz, Diana and Gerding, Hanne R. and Leist, Marcel} }

<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/25648"> <dcterms:rights rdf:resource="http://nbn-resolving.org/urn:nbn:de:bsz:352-20140905103605204-4002607-1"/> <dc:contributor>Pöltl, Dominik</dc:contributor> <dc:creator>Kullmann, Cornelius</dc:creator> <dc:language>eng</dc:language> <dcterms:issued>2013</dcterms:issued> <dc:creator>Efremova, Liudmila</dc:creator> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/25648"/> <dc:contributor>Schildknecht, Stefan</dc:contributor> <dc:contributor>Efremova, Liudmila</dc:contributor> <dc:contributor>Gutbier, Simon</dc:contributor> <dc:creator>Pöltl, Dominik</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-01-13T10:48:41Z</dcterms:available> <dc:creator>Leist, Marcel</dc:creator> <dc:creator>Gutbier, Simon</dc:creator> <dc:creator>Schildknecht, Stefan</dc:creator> <dc:contributor>Scholz, Diana</dc:contributor> <dc:creator>Karreman, Christiaan</dc:creator> <dc:contributor>Leist, Marcel</dc:contributor> <dcterms:abstract xml:lang="eng">Human differentiated cell types, such as neurons or hepatocytes, are of limited availability, and their use for experiments requiring ectopic gene expression is challenging. Using the human conditionally-immortalized neuronal precursor line LUHMES, we explored whether genetic modification in the proliferating state could be used for experiments in the differentiated post-mitotic neurons. First, alpha-synuclein (ASYN), a gene associated with the pathology of Parkinson’s disease, was overexpressed. Increased amounts of the protein were tolerated without change of phenotype, and this approach now allows further studies on protein variants. Knockdown of ASYN attenuated the toxicity of the parkinsonian toxicant 1-methyl-4-phenylpyridinium (MPP+). Different lentiviral constructs then were tested: cells labeled ubiquitously with green (GFP) or red fluorescent protein (RFP) allowed the quantification of neurite growth and of its disturbance by toxicants; expression of proteins of interest could be targeted to different organelles; production of two different proteins from a single read-through construct was achieved successfully by an expression strategy using a linker peptide between the two proteins, which is cleaved by deubiquitinases; LUHMES, labeled with GFP in the cytosol and RFP in the mitochondria, were used to quantify mitochondrial mobility along the neurites. MPP+ reduced such organelle movement before any other detectable cellular change, and this toxicity was prevented by simultaneous treatment with the antioxidant ascorbic acid. Thus, a strategy has been outlined here to study new functional endpoints, and subtle changes of structure and proteostasis relevant in toxicology and biomedicine in post-mitotic human cells.</dcterms:abstract> <dc:creator>Krug, Anne-Kathrin</dc:creator> <dc:contributor>Karreman, Christiaan</dc:contributor> <dcterms:bibliographicCitation>Alternatives to animal experimentation : ALTEX ; 30 (2013), 4. - S. 427-444</dcterms:bibliographicCitation> <dcterms:title>Generation of Genetically-Modified Human Differentiated Cells for Toxicological Tests and the Study of Neurodegenerative Diseases</dcterms:title> <dc:rights>deposit-license</dc:rights> <dc:creator>Scholz, Diana</dc:creator> <dc:contributor>Kullmann, Cornelius</dc:contributor> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-01-13T10:48:41Z</dc:date> <dc:creator>Gerding, Hanne R.</dc:creator> <dc:contributor>Gerding, Hanne R.</dc:contributor> <dc:contributor>Krug, Anne-Kathrin</dc:contributor> </rdf:Description> </rdf:RDF>

Dateiabrufe seit 01.10.2014 (Informationen über die Zugriffsstatistik)

Schildknecht_256487_flat.pdf 137

Das Dokument erscheint in:

KOPS Suche


Stöbern

Mein Benutzerkonto